(9aS)-octahydro-1H-pyrido[1,2-a]piperazine; oxalic acid, 95.0%, 100mg

2-(4-(Bromomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97.0%, 1g

5-(1-benzofuran-2-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 1g

2-Propylimidazole, 95.0%, 25g

2-(3-trifluoromethyl-phenyl)-DL-glycine, 97.0%, 10g

(S)-tert-Butyl (1-(2-bromophenyl)ethyl)carbamate, 95.0%, 1g

5-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine, 97%, 5g

6-Chloro-4-(trifluoromethyl)nicotinic acid, 97.0%, 5g

Single-use cuvettes Polystyrene, Macro, 2.5 to 4.5 ml, 100 Piece(s)

2,3-Dihydroxybenzoic acid, 97.0%, 5g

4-Hexyloxyphenol>98.0%(GC)25g

HEXADECYLTRIMETHYLAMMONIUM PERCHLORATE, 98%, 250mg

Methyl 3-bromobenzoate, 95.0%, 500g